DIAGNOSIS AND TREATMENT OF MILD AND MODERATE COGNITIVE IMPAIRMENTS
Issue:
4
Year:
2017
The paper defines cognitive functions and major syndromes of their impairments and considers the neurochemistry of these conditions. Special attention is paid to the diagnosis and treatment of non-dementia (mild and moderate) cognitive impairments (CIs); the latest diagnostic criteria for these CIs are given and the basic principles of their treatment described. A variety of clinical trials show that piribedil (Pronoran) is efficient in treating non-dementia CIs.
Keywords:
neurology
cognitive functions
non-dementia cognitive impairments
moderate cognitive impairment
mild cognitive impairment
piribedil
References:
- Diagnostic and statistical manual of mental diseases. 5 ed. (DSM-5) / London: American Psychiatric Association, 2013.
- Dementia. Comprehensive Principles and Practice / Oxford University Press, 2014; P. 377–83, 432–48.
- Zaharov V.V. Kognitivnye rasstrojstva bez dementsii: klassifikatsija, osnovnye prichiny i lechenie // Effektivnaja farmakoterapija. – 2016; 2: 22–30.
- Parfenov V.A., Zaharov V.V., Preobrazhenskaja I.S. Kognitivnye rasstrojstva / M., 2014; 192 s.
- Jahno N.N., Zaharov V.V., Lokshina A.B. i dr. Dementsii. Rukovodstvo dlja vrachej / M.: MedPress-inform, 2011; 272 s.
- Lokshina A.B. Legkie i umerennye kognitivnye rasstrojstva pri distsirkuljatornoj entsefalopatii. Dis. … kand. med. nauk. M., 2005; 138 s.
- Jahno N.N. Kognitivnye rasstrojstva v nevrologicheskoj klinike // Nevrol. zhurn. – 2006; 11 (Pril. 1): 4–12.
- Jahno N.N., Preobrazhenskaja I.S., Zaharov V.V. i dr. Rasprostranennost' kognitivnyh narushenij pri nevrologicheskih zabolevanijah (analiz raboty spetsializirovannogo ambulatornogo priema) // Nevrol., nejropsihiat., psihosomat. – 2012; 2: 30–5.
- Lokshina A.B. Sovremennye predstavlenija o nedementnyh kognitivnyh rasstrojstvah // Effektivnaja farmakoter. Nevrol. i psihiat. – 2015; 1: 36–44.
- Jessen F., Amariglio R., van Boxtel M. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease // Alzheimer’s Dement. – 2014; 10 (6): 844–52.
- Caracciolo B., Gatz M., Xu W. et al. Differential distribution of subjective and objective cognitive impairment in the population: A nationwide twin-study // J. Alzheimers Dis. – 2012; 29 (2): 393–403.
- Bäckman L., Ginovart N., Dixon R. et al. Age-related cognitive deficits mediated by changes in the striatal dopamine system // Am. J. Psychiatry. –2000; 157: 635–7.
- DeKeyser J., Herregodts P., Ebinger G. The mesoneocortical dopamine neuron system // Neurology. – 1990; 40: 1660–2.
- Aston-Jones G., Rajkowsky J., Cohen J. Role of locus coeruleus in attention and behavioral flexibility // Biol. Psychiatry. – 1999; 46: 1309–20.
- Levin O.S. Umerennoe kognitivnoe rasstrojstvo: diagnostika i lechenie // Effektivnaja farmakoter. Nevrol. i psihiat. – 2012; 5: 14–20.
- Zaharov V.V. Rasprostranennost' i lechenie kognitivnyh narushenij v nevrologicheskoj klinike. Rezul'taty Vserossijskogo issledovanija PROMETEJ) // Consilium Medicum. – 2008; 10 (2): 114–7.
- Zaharov V.V. Vserossijskaja programma issledovanij epidemiologii i terapii kognitivnyh rasstrojstv v pozhilom vozraste (PROMETEJ) // Nevrol. zhurn. – 2006; 11: 27–32.
- Zaharov V.V., Lokshina A.B. Primenenie preparata pronoran (piribedil) pri legkih kognitivnyh rasstrojstvah u pozhilyh bol'nyh s distsirkuljatornoj entsefalopatiej // Nevrol. zhurn. – 2004; 2: 30–5.
- Volkov N., Logan J., Fowler J. et al Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism // Am. J. Psychiatry. – 2000; 157 (1): 75–80.
- Nagaraia D., Jayashree S. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment // Am. J. Psychiatry. – 2001; 158 (9): 1517–9.
- Jahno N.N., Zaharov V.V., Strachunskaja E.Ja. i dr. Lechenie nedementnyh kognitivnyh narushenij u patsientov s arterial'noj gipertenziej i tserebral'nym aterosklerozom (Po dannym rossijskogo mul'titsentrovogo issledovanija FUETE) // Nevrol. zhurn. – 2012; 4: 49–55.
- Zaharov V.V., Milovanova O.V., Grishina D.A. i dr. Opyt primenenija pronorana v lechenii legkih i umerennyh kognitivnyh narushenij // Vrach. – 2017; 3: 32–7.